The (https://www.marketwatch.com/story/a-new-blood-test-can-help-detect-colon-cancer-but-its-not-as-good-as-the-test-you-hate-to-take-1c5716d0?mod=mw_rss_topstories) is getting headlines as a win for patient convenience. But here's what it actually signals: healthcare is so desperate to drive adoption that it's accepting a *worse* test. That's not innovation — that's desperation margin compression in real time.

Research these companies